Pacific Health Ventures

Investment decisions run through Managing Director Chris Furmanski, PhD, the firm's sole named principal. Furmanski's background spans DARPA, Boeing, Raytheon, Harvard, and the $3B Stanford Health Care system, where he led innovation. That operator-allocator profile suggests a sole decision-maker model, though the firm has not publicly disclosed an investment committee or additional investing partners.

The firm sources by identifying early-stage B2B health-tech startups and matching them with strategic healthcare partners that have specific technology or service gaps. Rather than waiting for inbound warm introductions, Pacific Health Ventures actively scouts companies whose products can slot into a strategic's roadmap, using the promise of a commercial partnership as both a sourcing magnet and a diligence signal. This matchmaking function is the firm's stated operational core.

Pacific Health Ventures markets itself as the opposite of a passive investor. The firm's website states explicitly: "We are not passive investors." It frames its value-add as matching startups with strategics and speeding product-market fit. Chris Furmanski sits on boards of several companies, per his biography, which implies an active post-investment governance role.

The firm targets early-stage companies — specifically startups that have developed an initial product and are ready to accelerate commercial adoption through a strategic partnership. The language of "matching early-stage startups with strategic industry partners" and "speeded product-market fit" places the firm at Seed through Series A, before a company has locked in enterprise distribution at scale.

The firm maintains offices in London, Boston, and Menlo Park, which implies at least transatlantic awareness if not active deployment capability. The website focuses its investment thesis on Silicon Valley B2B health tech, but the dual international office footprint suggests the firm operates with a multi-geography posture that could include European health systems and East Coast academic medicine.